Diana Gershstein

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
UNLABELLED Alternative treatment strategies for claudication are needed and cell-based therapies designed to induce angiogenesis are promising. The purpose of this report was to conduct a Phase I safety, dose-escalating, non-randomized, open-label study of autologous, fully differentiated venous endothelial and smooth muscle cells called MultiGeneAngio(More)
  • 1